Jean BergeronM.D., M.Sc., FRCPC

Carter S, Lemieux I, Li Z, Almeras N, Tremblay A, Bergeron J, Poirier P, Despres JP, Picard F

Changes in IGFBP-2 levels following a one-year lifestyle modification program are independently related to improvements in plasma apo B and LDL apo B levels.

Atherosclerosis, 281 , p. 89-97, 2019, ISSN: 0021-9150.

Résumé | Liens:

Brunham LR, Ruel I, Aljenedil S, Riviere JB, Baass A, Tu JV, Mancini GBJ, Raggi P, Gupta M, Couture P, Pearson GJ, Bergeron J, Francis GA, McCrindle BW, Morrison K, St-Pierre J, Henderson M, Hegele RA, Genest J, Goguen J, Gaudet D, Pare G, Romney J, Ransom T, Bernard S, Katz P, Joy TR, Bewick D, Brophy J

Canadian Cardiovascular Society Position Statement on Familial Hypercholesterolemia: Update 2018.

Can J Cardiol, 34 (12), p. 1553-1563, 2018, ISSN: 0828-282X.

Résumé | Liens:

Boyer M, Mitchell PL, Poirier DP, Almeras N, Tremblay A, Bergeron J, Despres JP, Arsenault BJ

Impact of a one-year lifestyle modification program on cholesterol efflux capacities in men with abdominal obesity and dyslipidemia.

Am J Physiol Endocrinol Metab, 315 (4), p. E460-E468, 2018, ISSN: 0193-1849.

Résumé | Liens:

Brunham LR, Ruel I, Khoury E, Hegele RA, Couture P, Bergeron J, Baass A, Dufour R, Francis GA, Cermakova L, Mancini GBJ, Brophy JM, Brisson D, Gaudet D, Genest J

Familial hypercholesterolemia in Canada: Initial results from the FH Canada national registry.

Atherosclerosis, 277 , p. 419-424, 2018, ISSN: 0021-9150.

Résumé | Liens:

Ruel I, Brisson D, Aljenedil S, Awan Z, Baass A, Belanger A, Bergeron J, Bewick D, Brophy JM, Brunham LR, Couture P, Dufour R, Francis GA, Frohlich J, Gagne C, Gaudet D, Gregoire JC, Gupta M, Hegele RA, Mancini GBJ, McCrindle BW, Pang J, Raggi P, Tu JV, Watts GF, Genest J

Simplified Canadian Definition for Familial Hypercholesterolemia.

Can J Cardiol, 34 (9), p. 1210-1214, 2018, ISSN: 0828-282X.

Résumé | Liens:

Marchand GB, Carreau AM, Weisnagel SJ, Bergeron J, Labrie F, Lemieux S, Tchernof A

Increased body fat mass explains the positive association between circulating estradiol and insulin resistance in postmenopausal women.

Am J Physiol Endocrinol Metab, 314 (5), p. E448-E456, 2018, ISSN: 0193-1849.

Résumé | Liens:

Drouin-Chartier JP, Tremblay AJ, Bergeron J, Laflamme N, Lamarche B, Couture P

Impact of lipoprotein apheresis with dextran-sulfate adsorption on the expression of genes involved in cardiovascular health in the blood of patients with homozygous familial hypercholesterolemia.

J Clin Apher, 33 (1), p. 104-107, 2018, ISSN: 0733-2459.

Résumé | Liens:

Ruel I, Aljenedil S, Sadri I, de Varennes E, Hegele RA, Couture P, Bergeron J, Wanneh E, Baass A, Dufour R, Gaudet D, Brisson D, Brunham LR, Francis GA, Cermakova L, Brophy JM, Ryomoto A, Mancini GBJ, Genest J

Imputation of Baseline LDL Cholesterol Concentration in Patients with Familial Hypercholesterolemia on Statins or Ezetimibe.

Clin Chem, 64 (2), p. 355-362, 2018, ISSN: 0009-9147.

Résumé | Liens:

Drouin-Chartier JP, Tremblay AJ, Bergeron J, Lamarche B, Couture P

High serum triglyceride concentrations in patients with homozygous familial hypercholesterolemia attenuate the efficacy of lipoprotein apheresis by dextran sulfate adsorption.

Atherosclerosis, 270 , p. 26-32, 2018, ISSN: 0021-9150.

Résumé | Liens:

Maltais A, Almeras N, Lemieux I, Tremblay A, Bergeron J, Poirier P, Despres JP

Trunk muscle quality assessed by computed tomography: Association with adiposity indices and glucose tolerance in men.

Metabolism, 85 , p. 205-212, 2018, ISSN: 0026-0495.

Résumé | Liens: